Cardiac implantable electronic device placement following alcohol septal ablation for hypertrophic cardiomyopathy in the United States.

Matthew C LamSrihari S NaiduDhaval KolteKevin KennedyDmitriy N FeldmanAntony F ChuJ Dawn AbbottPaul GordonHerbert D Aronow

Published in: Journal of cardiovascular electrophysiology (2020)

One in four HCM patients undergoing ASA underwent CIED implantation during their index hospitalization; nearly 2/3rd during the first 48 h postprocedure. Private hospital ownership independently predicted CIED placement. More data are needed to better understand the unexpectedly high rates of CIED placement, earlier than anticipated timing of implantation and differential rates by hospital ownership.

Keyphrases

hypertrophic cardiomyopathy
left ventricular
patients undergoing
healthcare
ultrasound guided
acute care
adverse drug
heart failure
big data
artificial intelligence
radiofrequency ablation